Clinical Trials · NCT03571594
A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Enrollment
- 76
- Start date
- Jun 2018
- Locations
- 1 site, United States
- Primary endpoint
- Number of participants with treatment emergent adverse events by severity